VanEck Biotech ETF

BBH

Market cap $350M

Overview Fund Activity

165.94 USD

+0.41

0.25%

At close Updated Sep 17, 3:21 PM EDT

1 day

0.25%

5 days

-1.22%

1 month

-0.19%

3 months

9.42%

6 months

0.97%

Year to date

5.67%

1 year

-8.25%

5 years

5.39%

10 years

23.84%

0

Funds holding %

of 7,463 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0.06% less ownership

Funds ownership: 34.73% [Q1] → 34.67% (-0.06%) [Q2]

4% less funds holding

Funds holding: 99 [Q1] → 95 (-4) [Q2]

10% less capital invested

Capital invested by funds: $127M [Q1] → $115M (-$12.3M) [Q2]

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

38% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 24

57% less call options, than puts

Call options by funds: $276K | Put options by funds: $644K

See Fund Rankings

Financial journalist opinion

CNBC Television

Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

Jared Holz, Mizuho healthcare strategist, joins 'Power Lunch' to discuss the change in sentiment in the healthcare sector, the differences in the biotech ETFs and much more.

Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

Zacks Investment Research

Should You Invest in the VanEck Biotech ETF (BBH)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December 20, 2011.

Should You Invest in the VanEck Biotech ETF (BBH)?

Zacks Investment Research

Should You Invest in the VanEck Biotech ETF (BBH)?

Launched on 12/20/2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

Should You Invest in the VanEck Biotech ETF (BBH)?

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Healthcare Sector Checkup As U.S. Looks To Change Regulations

BBH: Fear Of Price Controls Is Not The Problem

The executive order aims to reduce drug prices by allowing direct sales to consumers and cutting out PBMs but faces significant challenges. The main risk for biotech is FDA approval delays due to skepticism from newly appointed officials, impacting funding and development. The VanEck Biotech ETF offers lower risk with established companies, but 23% of AUM in speculative stocks poses a risk.

BBH: Fear Of Price Controls Is Not The Problem

Zacks Investment Research

Should You Invest in the VanEck Biotech ETF (BBH)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.

Should You Invest in the VanEck Biotech ETF (BBH)?

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Zacks Investment Research

Should You Invest in the VanEck Biotech ETF (BBH)?

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.

Should You Invest in the VanEck Biotech ETF (BBH)?

Zacks Investment Research

Should You Invest in the VanEck Biotech ETF (BBH)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.

Should You Invest in the VanEck Biotech ETF (BBH)?

VanEck Announces Year-End Distributions for VanEck Equity ETFs

NEW YORK--(BUSINESS WIRE)--VanEck has announced the 2024 annual distributions per share for its VanEck equity exchange-traded funds (ETFs).

VanEck Announces Year-End Distributions for VanEck Equity ETFs

See News Rankings

Charts implemented using Lightweight Charts™